Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (47)
  • 2025 (183)
  • 2024 (244)
  • 2023 (313)
  • 2022 (339)
  • 2021 (133)
  • 2020 (29)
  • 2019 (2)

Subject

  • Drug Trafficking (4206)
  • Synthetic drugs (1140)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (644)
  • Guilty Plea (558)
  • Seizures (Drugs/Property) (482)
  • Prescription Drugs (371)
  • Overdose (327)
  • Major Law Enforcement Operation (277)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (237)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (188)
  • Fentanyl Awareness (166)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (68)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (39)
  • Counterfeit Pills (38)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (13)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Guns/Weapons (1039)
  • Diversion Division (254)

Drug Name

  • Fentanyl (527)
  • Cocaine (441)
  • Methamphetamine (399)
  • Heroin (237)
  • Marijuana (Cannabis) (97)
  • Oxycodone (63)
  • Opioids (49)
  • Synthetic Opioids (32)
  • Ecstasy/MDMA (19)
  • Hydromorphone (16)
  • Benzodiazepines (9)
  • Morphine (7)
  • Ketamine (6)
  • Amphetamines (5)
  • Steroids (4)
  • K2/Spice (3)
  • LSD (3)
  • Methadone (3)
  • Psilocybin (3)
  • Marijuana Concentrates (2)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • New England (322)
  • Chicago (135)
  • Washington, DC (131)
  • St. Louis (122)
  • Seattle (115)
  • New York (98)
  • Miami (57)
  • El Paso (51)
  • New Jersey (48)
  • Atlanta (38)
  • San Francisco (36)
  • Dallas (26)
  • Houston (24)
  • Phoenix (18)
  • Sede (18)
  • New Orleans (12)
  • Los Angeles (9)
  • Rocky Mountain (9)
  • Omaha (7)
  • San Diego (6)
  • Louisville (5)
  • Detroit (3)
Clear All Results
1290 Results - Showing 1281 to 1290
PRESS RELEASE

24 defendants charged in joint federal and state investigation of two violent street gangs on the West Side of Chicago

CHICAGO -- Twenty-four individuals are facing federal charges following an investigation targeting two street gangs responsible for firearms offenses, narcotics trafficking, and violence on the West Side of Chicago. During the investigation, dubbed “Operation Full Circle,” federal, state, and local law enforcement officers worked together to seize 34 firearms, more...
PRESS RELEASE

Mexican national pleads guilty to drug conspiracy and gun offenses

FRESNO, Calif. — Javier Ochoa-Anaya, 49, residing in Denair, California pled guilty today to conspiracy to distribute methamphetamine and possessing firearms in furtherance of drug trafficking offenses, U.S. Attorney McGregor W. Scott and Drug Enforcement Administration Special Agent in Charge Daniel C. Comeaux announced. According to the plea agreement, Ochoa...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...
PRESS RELEASE

Omnicare agrees to pay over $15 Million to resolve allegations it improperly dispensed opioids at long-term care facilities

PORTLAND, Ore.—Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by, among other things, allowing opioids and other controlled substances to be...
PRESS RELEASE

Wisconsin physician agrees to pay penalties to resolve allegations of prescribing opioids illegally and violating False Claims Act

MILWAUKEE - DEA Assistant Special Agent in Charge Paul E. Maxwell and United States Attorney Matthew D. Krueger announced today that Dr. Mehran Heydarpour of Brookfield, Wisconsin, agreed to pay $175,000 to resolve allegations that he prescribed opioid pain medications in violation of the Controlled Substances Act and that he...
PRESS RELEASE

St. Louis County doctor pleads guilty to fraudulently obtaining opioid narcotic prescription drugs

ST. LOUIS – Angela K. Williams, M.D., 34, of Brentwood, Missouri, pleaded guilty today to one felony charge of fraudulently obtaining oxycodone, a narcotic opioid prescription drug. This case was investigated by the Drug Enforcement Administration St. Louis Division, the Florissant Police Department, the Town and Country Police Department, and...
PRESS RELEASE

Champaign man sentenced to 13 years in prison for trafficking

URBANA, Ill. – U.S. District Judge Michael M. Mihm today sentenced a Champaign, ll., man, Stephan Caamano, to 13 years in federal prison for trafficking at least 4.3 million counterfeit Xanax pills throughout the country and laundering the proceeds. Caamano has been ordered to pay more than $2.1 million he...
PRESS RELEASE

DEA Honolulu statement regarding practitioner scam

HONOLULU – The United States Drug Enforcement Administration in Honolulu urges its DEA-registered practitioners to be cautious of telephone calls from criminals posing as DEA agents or other law enforcement personnel demanding the practitioner provide their DEA-registrant number and other practitioner-related sensitive information over the telephone. Most recently, the DEA...
PRESS RELEASE

DEA to host free Rx prescriber conference

LOUISVILLE, Ky. - The United States Drug Enforcement Administration today announced that it will be hosting a regional Practitioner Diversion Awareness Conference (PDAC) on March 27, 2019. The PDAC is designed to educate and assist doctors, veterinarians, dentists, physician assistants, and nurse practitioners across the Commonwealth of Kentucky in identifying...

Paginación

  • Primera página «
  • Anterior
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • Page 128
  • Current page 129
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster